Gastrointestinal immunity plays a crucial role in defending the body against pathogens while maintaining tolerance to the trillions of microbes inhabiting the gut. The gut-associated lymphoid tissue (GALT) comprises Peyer's patches, lymph nodes, and other immune structures that coordinate immune responses in the digestive tract. Specialized immune cells, such as intraepithelial lymphocytes and mucosa-associated lymphoid tissue, contribute to the surveillance of the intestinal lining. Immunoglobulin A (IgA) antibodies, abundantly produced in the gastrointestinal mucosa, play a central role in neutralizing pathogens and regulating the gut microbiota. Tolerance mechanisms prevent the immune system from overreacting to harmless antigens or commensal bacteria, maintaining homeostasis. Gastrointestinal infections and inflammatory conditions, like inflammatory bowel disease (IBD), can result from dysregulation of gastrointestinal immunity. The gut-brain axis highlights the interconnectedness of gastrointestinal and neurological functions. Nutrition, particularly components like dietary fiber, influences gastrointestinal immunity. Probiotics and prebiotics contribute to a healthy gut microbiota, positively impacting immune function. Understanding the intricate balance of gastrointestinal immunity is vital for addressing digestive disorders and promoting overall health. Ongoing research explores the modulation of gut immunity for therapeutic interventions and the potential links between gut health and systemic conditions.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe